FDA Inspection 1123990 — Opella Healthcare International SAS

Opella Healthcare International SAS — FEI 3003492806

The FDA completed an inspection of Opella Healthcare International SAS on October 31, 2019 in Compiegne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 31, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Compiegne (France)

Additional Details

Mutual Recognition Agreement (MRA)